A carregar...

Systemic Teriparatide Administration Promotes Osseous Regeneration of an Intrabony Defect: A Case Report

INTRODUCTION: Teriparatide comprises the first 34 amino acids of parathyroid hormone and is a systemic anabolic agent that is Food and Drug Administration approved for the treatment of osteoporosis but not for periodontitis. To our knowledge, this is the first clinical case report to document the tr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clinic Adv Periodontics
Main Authors: Bashutski, Jill D., Kinney, Janet S., Benavides, Erika, Maitra, Samopriyo, Braun, Thomas M., Giannobile, William V., McCauley, Laurie K., Eber, Robert M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4623592/
https://ncbi.nlm.nih.gov/pubmed/26525954
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1902/cap.2012.110043
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!